Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (178)

1

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Harvey-Jones, E. | Raghunandan, M. | Robbez-Masson, L. | +36

2

Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment

enthalten in: Cancer letters | 2024

von Madorsky Rowdo, F. | Xiao, G. | Khramtsova, G. | +23

UpdateOf: bioRxiv. 2023 Jun 22;:. - PMID 38076873

3

Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor

enthalten in: Japanese journal of clinical oncology | 2024

von Akahira, R. | Fukuda, K. | Shimazu, K. | +5

4

BRCA1/2 reversion mutations in a pan-cancer cohort

enthalten in: Cancer science | 2024

von Nakamura, K. | Hayashi, H. | Kawano, R. | +20

5

Targeting BRCA and PALB2 in Pancreatic Cancer

enthalten in: Current treatment options in oncology | 2024

von Anbil, S. | Reiss, K.

6

Targeting the DNA repair pathway for breast cancer therapy : Beyond the molecular subtypes

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Qu, Y. | Qin, S. | Yang, Z. | +11

7

The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489

enthalten in: Cells | 2023

von Soung, Y. | Ju, J. | Chung, J.

8

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors : Still looking through a dirty glass window?

enthalten in: Cancer treatment reviews | 2023

von Incorvaia, L. | Perez, A. | Marchetti, C. | +21

9

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

enthalten in: International journal of molecular sciences | 2023

von Ghosh, M. | Kang, M. | Katuwal, N. | +5

10

BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy

enthalten in: Journal of ovarian research | 2023

von Farokhi Boroujeni, S. | Rodriguez, G. | Galpin, K. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]